Tc-99m mebrofenin hepatobiliary scintigraphy to assess future liver remnant function before major liver surgery.

Détails

Ressource 1Télécharger: 37638473.pdf (953.46 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_320D6A0EAFB8
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Tc-99m mebrofenin hepatobiliary scintigraphy to assess future liver remnant function before major liver surgery.
Périodique
Journal of surgical oncology
Auteur⸱e⸱s
Smet H., Martin D. (co-premier), Uldry E., Duran R., Girardet R., Schaefer N., Prior J.O., Denys A., Halkic N., Demartines N., Melloul E.
ISSN
1096-9098 (Electronic)
ISSN-L
0022-4790
Statut éditorial
Publié
Date de publication
12/2023
Peer-reviewed
Oui
Volume
128
Numéro
8
Pages
1312-1319
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Assessment of liver function is paramount before hepatectomy. This study aimed to assess future liver remnant function (FLR-F) using hepatobiliary scintigraphy (HBS) and to compare it to FLR volume (FLR-V) in the prediction of posthepatectomy liver failure (PHLF). The impact of volume and function gains were also assessed in patients undergoing portal vein embolization (PVE) or liver venous deprivation (LVD).
All consecutive patients undergoing major hepatectomy between 02/2018 and 09/2021 with preoperative HBS were included. FLR-V was expressed as percentage of total liver volume and analyzed using preoperative computed tomography. FLR-V and FLR-F gains after embolization were expressed in percentage. Receiver operating characteristic analysis was performed to compare both methods in predicting PHLF.
Thirty-six patients were included. PVE and LVD were performed in 4 (11%) and 28 patients (78%), respectively. Overall, PHLF occurred in eight patients (22%). FLR-F gain after embolization showed significant ability to predict PHLF (area under the curve [AUC] = 0.789), with cut-off value of 150% showing a sensitivity of 1.00, a specificity of 0.42, and a negative predictive value of 1.00.
Preoperative HBS shows a high sensitivity to predict PHLF when HBS is performed twice to measure the function gain after venous embolization.
Mots-clé
Humans, Liver Function Tests, Liver/diagnostic imaging, Liver/surgery, Hepatectomy/adverse effects, Hepatectomy/methods, Liver Failure/diagnostic imaging, Liver Failure/etiology, Radionuclide Imaging, Liver Neoplasms/surgery, Embolization, Therapeutic, Portal Vein/diagnostic imaging, Retrospective Studies, hepatectomy, hepatobiliary scintigraphy, liver failure, liver function test
Pubmed
Web of science
Open Access
Oui
Création de la notice
29/08/2023 9:32
Dernière modification de la notice
25/02/2024 8:19
Données d'usage